Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings Inc (NQ: HRMY )

41.69 -0.11 (-0.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 751,242
Open 41.70
Bid (Size) 41.44 (1)
Ask (Size) 42.07 (1)
Prev. Close 41.80
Today's Range 40.66 - 41.89
52wk Range 33.04 - 62.09
Shares Outstanding 59,620,731
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
These healthcare stocks to buy offer spectacular upside potential ahead in your defensive portfolio as we get deeper into 2023. 
Via InvestorPlace
The Latest Analyst Ratings for Harmony Biosciences
 
Via Benzinga

Performance

YTD
-21.28%
-21.28%
1 Month
-9.57%
-9.57%
3 Month
-24.65%
-24.65%
6 Month
-0.88%
-0.88%
1 Year
-18.46%
-18.46%

More News

Read More
Harmony Biosciences (HRMY) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Harmony Biosciences, The No. 3 Biotech, Just Topped Forecasts; But Concerns Persist
Via Investor's Business Daily
Big Retailers Report
Via Benzinga
With This Big Transition Ahead, Is Novavax a Buy?
Via The Motley Fool
4 Analysts Have This to Say About Harmony Biosciences
Via Benzinga
Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
From Harmony Biosciences
Via Globe NewsWire
Alkermes Stock Sees Rising Relative Price Strength
Via Investor's Business Daily
Anavex Life Sciences Stock Shows Improved Price Strength Rating
Via Investor's Business Daily
The 7 Best Biotech Stocks to Buy for February 2023
Via InvestorPlace
7 Healthcare Stocks That Will Be Big Winners in 2023
Via InvestorPlace
If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today
Via The Motley Fool
2 Biotechs Making Waves With A Single Product in their Pipeline
Via MarketBeat
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
NVAX Stock Alert: What to Know as Novavax Names New CEO
Via InvestorPlace
Moderna Stock Shows Surprising Strength; Key Rating Upgraded
Via Investor's Business Daily
BeiGene Stock Shows Market Leadership With Jump To 82 RS Rating
Via Investor's Business Daily
Xenon Pharmaceuticals Stock Scores Rising Relative Strength Upgrade
Via Investor's Business Daily
BioCryst Pharmaceuticals Stock Sees RS Rating Rise To 84
Via Investor's Business Daily
Looking Into Harmony Biosciences's Return On Capital Employed
Via Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Via Benzinga
Gartner, Sony, Uber And Other Big Gainers From Tuesday
Via Benzinga
Harmony Biosciences Holdings, Inc. (HRMY) Q3 2022 Earnings Call Transcript
Via The Motley Fool
Why IBD 50 Stock Harmony Biosciences Flew To The High End Of Its Buy Zone
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.